We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Tucatinib Against Stage IV HER2+ Breast Cancer, Phase III Trial Results Promising

News   Dec 12, 2019 | Original story from University of Colorado Cancer Center

 
Tucatinib Against Stage IV HER2+ Breast Cancer,  Phase III Trial Results Promising
 
 
 

RELATED ARTICLES

Liver Fibrosis “Off Switch” Could Help Fight Alcoholic Liver Disease

News

Understanding the process of liver fibrosis, could help researchers develop new ways to prevent or treat conditions such as alcoholic liver disease. A team has now demonstrated for the first time that liver fibrosis progression could potentially be targeted by manipulating a special population of liver cells.

READ MORE

Immune Cells Aid Invasion of Brain Tumors

News

A team has analyzed the role of immune cells in the expansion of glioblastoma, a type of aggressive brain tumor.

READ MORE

Taking Aim at Gastric Cancer

News

A team has discovered that a novel drug, called “FerriIridium”, is capable of simultaneously diagnosing and treating gastric cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE